Industry Overview

Interventional radiology market was valued at $30,336.0 million in 2025 and is projected to reach $49,693.6 million by 2035, growing at a CAGR of 5.1% during the forecast Period (2026-2035). The market is expected to grow significantly, driven by the rising prevalence of chronic diseases, the increasing demand for minimally invasive procedures, and rapid advancements in imaging and AI technologies. Key factors also include the expanded use of interventional radiology in areas like oncology and cardiology, growing patient and physician awareness of its benefits (such as shorter hospital stays and lower costs), and new product launches. However, challenges include the shortage of skilled radiologists and the high cost of some advanced equipment.

Market Dynamics

Rising Burden of Chronic Diseases & Aging Population

The growing prevalence of chronic diseases such as cardiovascular disorders, cancer, neurological conditions, and peripheral artery disease is a major catalyst for interventional radiology adoption. These conditions often require ongoing, image?guided interventions (e.g., angioplasty, embolization, ablation), which IR is uniquely suited to deliver. As global populations age, the number of elderly patients with comorbidities also rises, amplifying demand for minimally invasive procedures that offer lower risk, shorter hospital stays, and faster recovery compared to open surgery.

Technological Innovation in Imaging & Procedural Tools

Technological advancements are at the heart of the IR market growth. The integration of high?resolution imaging (CT, MRI, fluoroscopy), 3D/4D visualization, AI-assisted image analysis, and augmented reality is making interventions more precise and safer. Moreover, the development of hybrid suites, robotic-assisted systems, and AI-powered navigation enables radiologists to perform more complex procedures with higher confidence and control. These innovations not only increase the procedural success rate but also open up new use cases and improve workflow efficiency.

Shift Towards Minimally Invasive Procedures & Cost Efficiency

There is a strong global shift in clinical practice toward minimally invasive therapies because they reduce patient trauma, lower complication rates, and shorten recovery time, factors that are highly valued by both patients and health systems. These benefits translate into lower overall healthcare costs, especially when procedures can be performed in outpatient settings or ambulatory surgical centers, rather than in full hospital operating rooms. Additionally, rising patient awareness about the advantages of IR over conventional surgery is fueling adoption, as is the expansion of healthcare infrastructure in emerging markets that supports more IR-capable facilities.

Market Segmentation

• Based on the product, the market is segmented into angiography systems, CT scan, fluoroscopy systems, MRI systems, ultrasound imaging systems, and others.
• Based on the application, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and others.
• Based on the procedure, the market is segmented into angiography, angioplasty, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures.

Angiography Systems Segment to Grow at a Considerable Market Share

The angiography systems segment under the Product category emerges as the single largest contributor and the segment expected to lead the market throughout the forecast period. This dominance is primarily driven by the rising global burden of cardiovascular diseases, which remain the leading cause of mortality worldwide, thereby significantly increasing the demand for precise vascular imaging solutions. Angiography systems are indispensable for diagnosing and guiding minimally invasive procedures such as angioplasty, embolization, and thrombectomy, making them central to interventional radiology workflows.

Continuous advancements in digital flat-panel detectors, 3D imaging, and dose-reduction technologies further strengthen adoption in hospitals and specialty centers. Additionally, the growing preference for image-guided interventions over open surgeries, expanding availability of hybrid operating rooms, and increasing investments in advanced radiology infrastructure in emerging economies further solidify the segment’s leadership. As a result, angiography systems hold the largest market share and are poised to maintain market leadership due to their essential role in high-volume cardiovascular and neurovascular interventions.

Regional Outlook

The global interventional radiology market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Region to Hold a Substantial Growth Rate

North America, particularly the US, dominates the global interventional radiology Market and holds the largest share, driven by its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of leading medical imaging manufacturers. The country benefits from a well-established hospital network equipped with state-of-the-art angiography, fluoroscopy, CT, MRI, and ultrasound systems, enabling widespread use of interventional radiology across cardiology, oncology, neurology, and urology. The high prevalence of chronic diseases, particularly cardiovascular disorders, cancer, and renal complications, continues to fuel demand for image-guided interventions, which offer shorter recovery times and reduced hospitalization costs.

Additionally, the US leads in research, innovation, and clinical adoption of advanced technologies such as AI-assisted imaging, hybrid operating rooms, and robotic interventional systems, further strengthening its market position. Favorable reimbursement policies for interventional radiology procedures, coupled with strong investments by companies like GE HealthCare, Siemens Healthineers, Philips, and Canon Medical Systems, sustain technological advancements and accessibility. The presence of a highly skilled workforce, continuous training programs, and strong collaboration between hospitals, universities, and industry innovators collectively ensure that the United States maintains its dominant share in the global market.

Market Players Outlook

The major companies operating in the global interventional radiology market include Boston Scientific Corp., GE Healthcare, Koninklijke Philips N.V., Medtronic, Siemens Healthineers, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.

Recent Developments

• In November 2025, Canon Medical received FDA clearance for its new Alphenix 4D CT system, which combines angiography and computed tomography. Set to be showcased at the RSNA 2025 meeting and commercially available in summer 2026, this hybrid solution serves various fields, including interventional radiology, neurology, trauma, stroke, and pediatrics. The system features high-definition flat panel detector technology, a wide-area detector, and Canon’s Precise IQ Engine for enhanced image quality and dose reduction. Additionally, it boasts a rapid 0.24-second rotation speed for full organ coverage in a single rotation.
• In March 2025, Gleneagles Hospital Bengaluru launched an Advanced Interventional Radiology Cath Lab at its Richmond Road facility, inaugurated by Health Minister Dinesh Gundu Rao. This state-of-the-art lab is designed for precision-driven vascular and non-vascular interventions, including tumor ablations and embolization procedures, utilizing cutting-edge image-guided technology.

The Report Covers

• Market value data analysis for 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global interventional radiology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.